Literature DB >> 21799647

T1-weighted dual-echo MRI for fat quantification in pediatric nonalcoholic fatty liver disease.

Lucia Pacifico1, Michele Di Martino, Carlo Catalano, Valeria Panebianco, Mario Bezzi, Caterina Anania, Claudio Chiesa.   

Abstract

AIM: To determine in obese children with nonalcoholic fatty liver disease (NAFLD) the accuracy of magnetic resonance imaging (MRI) in assessing liver fat concentration.
METHODS: A case-control study was performed. Cases were 25 obese children with biopsy-proven NAFLD. Controls were 25 obese children matched for age and gender, without NAFLD at ultrasonography and with normal levels of aminotransferases and insulin. Hepatic fat fraction (HFF) by MRI was obtained using a modification of the Dixon method.
RESULTS: HFF ranged from 2% to 44% [mean, 19.0% (95% CI, 15.1-27.4)] in children with NAFLD, while in the controls this value ranged from 0.08% to 4.69% [2.0% (1.3-2.5), P < 0.0001]. HFF was highly correlated with histological steatosis (r = 0.883, P < 0.0001) in the NAFLD children. According to the histological grade of steatosis, the mean HFF was 8.7% (95% CI, 6.0-11.6) for mild, 21.6% (15.3-27.0) for moderate, and 39.7% (34.4-45.0) for severe fatty liver infiltration. With a cutoff of 4.85%, HFF had a sensitivity of 95.8% for the diagnosis of histological steatosis ≥ 5%. All control children had HFF lower than 4.85%; thus, the specificity was 100%. After 12 mo, children with weight loss displayed a significant decrease in HFF.
CONCLUSION: MRI is an accurate methodology for liver fat quantification in pediatric NAFLD.

Entities:  

Keywords:  Children; Fast-magnetic resonance imaging; Liver fat quantification; Nonalcoholic fatty liver disease; Obesity

Mesh:

Substances:

Year:  2011        PMID: 21799647      PMCID: PMC3132252          DOI: 10.3748/wjg.v17.i25.3012

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  32 in total

1.  Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma.

Authors:  Elisabetta Bugianesi; Nicola Leone; Ester Vanni; Giulio Marchesini; Franco Brunello; Patrizia Carucci; Alessandro Musso; Paolo De Paolis; Lorenzo Capussotti; Mauro Salizzoni; Mario Rizzetto
Journal:  Gastroenterology       Date:  2002-07       Impact factor: 22.682

2.  Hepatic iron and nonalcoholic fatty liver disease.

Authors:  Z M Younossi; T Gramlich; B R Bacon; C A Matteoni; N Boparai; R O'Neill; A J McCullough
Journal:  Hepatology       Date:  1999-10       Impact factor: 17.425

3.  Pediatric nonalcoholic fatty liver disease: A clinical and laboratory challenge.

Authors:  Lucia Pacifico; Eleonora Poggiogalle; Vito Cantisani; Guendalina Menichini; Paolo Ricci; Flavia Ferraro; Claudio Chiesa
Journal:  World J Hepatol       Date:  2010-07-27

4.  Insulin sensitivity among obese children and adolescents, according to degree of weight loss.

Authors:  Thomas Reinehr; Wieland Kiess; Thomas Kapellen; Werner Andler
Journal:  Pediatrics       Date:  2004-12       Impact factor: 7.124

Review 5.  Non-invasive assessment and quantification of liver steatosis by ultrasound, computed tomography and magnetic resonance.

Authors:  Nina F Schwenzer; Fabian Springer; Christina Schraml; Norbert Stefan; Jürgen Machann; Fritz Schick
Journal:  J Hepatol       Date:  2009-06-11       Impact factor: 25.083

6.  The diagnostic accuracy of US, CT, MRI and 1H-MRS for the evaluation of hepatic steatosis compared with liver biopsy: a meta-analysis.

Authors:  Anneloes E Bohte; Jochem R van Werven; Shandra Bipat; Jaap Stoker
Journal:  Eur Radiol       Date:  2010-07-31       Impact factor: 5.315

7.  Central role of fatty liver in the pathogenesis of insulin resistance in obese adolescents.

Authors:  Ebe D'Adamo; Anna M G Cali; Ram Weiss; Nicola Santoro; Bridget Pierpont; Veronika Northrup; Sonia Caprio
Journal:  Diabetes Care       Date:  2010-08       Impact factor: 17.152

8.  Nonalcoholic fatty liver disease and carotid atherosclerosis in children.

Authors:  Lucia Pacifico; Vito Cantisani; Paolo Ricci; John F Osborn; Elisa Schiavo; Caterina Anania; Eva Ferrara; Giuliano Dvisic; Claudio Chiesa
Journal:  Pediatr Res       Date:  2008-04       Impact factor: 3.756

9.  Usefulness of chemical-shift MRI in discriminating increased liver echogenicity in glycogenosis.

Authors:  C Pozzato; C Dall'asta; G Radaelli; M Torcoletti; A Formenti; E Riva; G Cornalba; A E Pontiroli
Journal:  Dig Liver Dis       Date:  2007-07-25       Impact factor: 4.088

10.  Establishing a standard definition for child overweight and obesity worldwide: international survey.

Authors:  T J Cole; M C Bellizzi; K M Flegal; W H Dietz
Journal:  BMJ       Date:  2000-05-06
View more
  26 in total

1.  Hepatic fat quantification magnetic resonance for monitoring treatment response in pediatric nonalcoholic steatohepatitis.

Authors:  Hong Koh; Seung Kim; Myung-Joon Kim; Hyun Gi Kim; Hyun Joo Shin; Mi-Jung Lee
Journal:  World J Gastroenterol       Date:  2015-09-07       Impact factor: 5.742

2.  Magnetic resonance imaging and liver histology as biomarkers of hepatic steatosis in children with nonalcoholic fatty liver disease.

Authors:  Jeffrey B Schwimmer; Michael S Middleton; Cynthia Behling; Kimberly P Newton; Hannah I Awai; Melissa N Paiz; Jessica Lam; Jonathan C Hooker; Gavin Hamilton; John Fontanesi; Claude B Sirlin
Journal:  Hepatology       Date:  2015-02-05       Impact factor: 17.425

3.  Changes of liver fat content and transaminases in obese children after 12-mo nutritional intervention.

Authors:  Elvira Verduci; Carlo Pozzato; Giuseppe Banderali; Giovanni Radaelli; Chiara Arrizza; Antonio Rovere; Enrica Riva; Marcello Giovannini
Journal:  World J Hepatol       Date:  2013-09-27

4.  Correlation between liver histology and novel magnetic resonance imaging in adult patients with non-alcoholic fatty liver disease - MRI accurately quantifies hepatic steatosis in NAFLD.

Authors:  Z Permutt; T-A Le; M R Peterson; E Seki; D A Brenner; C Sirlin; R Loomba
Journal:  Aliment Pharmacol Ther       Date:  2012-05-03       Impact factor: 8.171

5.  Increased circulating zonulin in children with biopsy-proven nonalcoholic fatty liver disease.

Authors:  Lucia Pacifico; Enea Bonci; Lidia Marandola; Sara Romaggioli; Stefano Bascetta; Claudio Chiesa
Journal:  World J Gastroenterol       Date:  2014-12-07       Impact factor: 5.742

Review 6.  Evidence and recommendations for imaging liver fat in children, based on systematic review.

Authors:  Hannah I Awai; Kimberly P Newton; Claude B Sirlin; Cynthia Behling; Jeffrey B Schwimmer
Journal:  Clin Gastroenterol Hepatol       Date:  2013-09-30       Impact factor: 11.382

7.  Pancreatic fat and β-cell function in overweight/obese children with nonalcoholic fatty liver disease.

Authors:  Lucia Pacifico; Michele Di Martino; Caterina Anania; Gian Marco Andreoli; Mario Bezzi; Carlo Catalano; Claudio Chiesa
Journal:  World J Gastroenterol       Date:  2015-04-21       Impact factor: 5.742

Review 8.  Pediatric fatty liver disease: role of ethnicity and genetics.

Authors:  Pierluigi Marzuillo; Emanuele Miraglia del Giudice; Nicola Santoro
Journal:  World J Gastroenterol       Date:  2014-06-21       Impact factor: 5.742

9.  Adipokines and C-reactive protein in relation to bone mineralization in pediatric nonalcoholic fatty liver disease.

Authors:  Lucia Pacifico; Mario Bezzi; Concetta Valentina Lombardo; Sara Romaggioli; Flavia Ferraro; Stefano Bascetta; Claudio Chiesa
Journal:  World J Gastroenterol       Date:  2013-07-07       Impact factor: 5.742

10.  Effect of colesevelam on liver fat quantified by magnetic resonance in nonalcoholic steatohepatitis: a randomized controlled trial.

Authors:  Thuy-Anh Le; Joshua Chen; Christopher Changchien; Michael R Peterson; Yuko Kono; Heather Patton; Benjamin L Cohen; David Brenner; Claude Sirlin; Rohit Loomba
Journal:  Hepatology       Date:  2012-07-02       Impact factor: 17.425

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.